The effects of PDE6D on stemness-related clonogenicity (Figure 3) and sorafenib resistance (Figure 4) prompted us to explore whether TGF-β might be involved in the regulation of PDE6D in HCC. The gene discussed is PDE6D; the disease is hepatocellular carcinoma.